Lunai Bioworks Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Suite 906 Los Angeles, CA
LNAI chart
What traders are saying about $LNAI
Latest postsLunai Bioworks Inc. news
- Lunai Bioworks Inc. (LNAI) Seasonal returns chart
Yahoo Finance UK ·
- Lunai Bioworks Announces Receipt of Nasdaq Determination and Intention to Voluntarily Delist and Deregister
Yahoo Finance ·
- Lunai Bioworks (NASDAQ: LNAI) Expands Parkinson's Platform Through Exclusive Tanaist Agreement
Yahoo Finance ·
- Lunai Bioworks (Nasdaq: LNAI) Demonstrates AI Chemical-Risk Screening for Generative AI
Yahoo Finance ·
- Lunai Bioworks (Nasdaq: LNAI) Names Six Broker-Dealers in Expanded Naked Short Selling Suit
Yahoo Finance ·
- Lunai Bioworks (Nasdaq: LNAI) Signs Definitive Collaboration Agreement with BrainStorm Therapeutics; Initial Parkinson's Disease Data Readout Targeted for First Half of 2027
Yahoo Finance ·
- Lunai Bioworks (Nasdaq: LNAI) Names 10 Defendants in Naked Short Selling Fraud Suit
Yahoo Finance ·
- LUNAI BIOWORKS: CEO LETTER TO SHAREHOLDERS
Yahoo Finance ·
- Why Did LNAI Stock Soar Over 100% In Pre-Market Trading Today?
stocktwits.com ·
- Lunai Bioworks and BrainStorm Therapeutics Launch Foundation-Funded Parkinson's and Rare Epilepsy AI Discovery Collaboration
Yahoo Finance ·
- LUNAI BIOWORKS, INC. ANNOUNCES REVERSE STOCK SPLIT
Yahoo Finance ·
- Oncotelic Therapeutics Announces Closing of a Strategic Monetization of Its CNS/Nasal Assets with Lunai Bioworks, Advancing Joint Development in Biodefense and Alzheimer’s Disease
Yahoo Finance ·
Lunai Bioworks Inc. key financials
| USD | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $51,992 | – | – | – |
| Net income | -$3.6M | -$178.0M | -$88.4M | -$39.7M |
| Diluted EPS | $-1.06 | $-86.27 | $-0.91 | $-0.71 |
| Total assets (year end) | – | $6.7M | $111.3M | $58.0M |
| Cash and equivalents (year end) | – | $491,645 | $311,764 | $243,980 |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Lunai Bioworks Inc.
- Ticker
- LNAI (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Suite 906 Los Angeles, CA
- Incorporated in
- DE
- Fiscal year end
- June 30
- SEC CIK
- 1527728
- Former names
- RENOVARO INC., RENOVARO BIOSCIENCES INC., Enochian Biosciences Inc
Frequently asked questions
What exchange is Lunai Bioworks Inc. listed on?
Lunai Bioworks Inc. trades on the Nasdaq under the ticker symbol LNAI.
What industry is Lunai Bioworks Inc. in?
Lunai Bioworks Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Lunai Bioworks Inc. headquartered?
Lunai Bioworks Inc.'s business address on file with the SEC is in Suite 906 Los Angeles, CA.
When does Lunai Bioworks Inc.'s fiscal year end?
Lunai Bioworks Inc.'s fiscal year ends on June 30.
How much revenue did Lunai Bioworks Inc. report?
Lunai Bioworks Inc. reported $51,992 in revenue for calendar year 2026, according to its SEC filings.